Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 5, 2012, Pages 919-927

  Prideaux, Lani ^a   Kamm, Michael A ^a   De Cruz, Peter ^a   Williams, James ^b   Bell, Sally J ^a   Connell, William R ^a   Brown, Steven J ^a   Lust, Mark ^a   Desmond, Paul V ^a   Chan, Heyson ^d   Chow, Dorothy K L ^d   Wu, Justin C Y ^d   Leong, Rupert W ^c,d   Sung, Joseph J ^d   Chan, Francis K L ^d   Ng, Siew C ^a,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Asia; Crohn's disease; Ethnicity; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

CYCLOSPORIN; IMMUNOMODULATING AGENT; MERCAPTOPURINE; METHOTREXATE; STEROID; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ARTICLE; AUSTRALIA; CLINICAL FEATURE; COLON RESECTION; COMPARATIVE STUDY; CROHN DISEASE; DRUG USE; ENTERITIS; FAMILY HISTORY; FEMALE; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; ULCERATIVE COLITIS;

EID: 84860234539     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06984.x     Document Type: Article

References (50)

1. Thia KT, Loftus EV Jr, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am. J. Gastroenterol. 2008; 103: 3167-82.
2. Wilson J, Hair C, Knight R etal. High incidence of inflammatory bowel disease in Australia: a prospective population-based Australian incidence study. Inflamm. Bowel Dis. 2010; 16: 1550-6.
3. Leong RW, Lau JY, Sung JJ. The epidemiology and phenotype of Crohn's disease in the Chinese population. Inflamm. Bowel Dis. 2004; 10: 646-51.
4. Ouyang Q, Tandon R, Goh KL. Management consensus of inflammatory bowel disease for the Asia-Pacific region. J. Gastroenterol. Hepatol. 2006; 21: 1772-82.
5. Wang YF, Zhang H, Ouyang Q. Clinical manifestations of inflammatory bowel disease: East and West differences. J. Dig. Dis. 2007; 8: 121-7.
6. Luo CH, Wexner SD, Liu QS, Li L, Weiss E, Zhao RH. The differences between American and Chinese patients with Crohn's disease. Colorectal Dis. 2011; 13: 166-70.
7. Cao Q, Si JM, Gao M, Zhou G, Hu WL, Li JH. Clinical presentation of inflammatory bowel disease: a hospital based retrospective study of 379 patients in eastern China. Chin. Med. J. 2005; 118: 747-52.
8. Jiang L, Xia B, Li J etal. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Inflamm. Bowel Dis. 2006; 12: 212-17.
9. Wang Y, Ouyang Q. Ulcerative colitis in China: retrospective analysis of 3100 hospitalized patients. J. Gastroenterol. Hepatol. 2007; 22: 1450-5.
10. Chow DK, Leong RW, Tsoi KK etal. Long-term follow-up of ulcerative colitis in the Chinese population. Am. J. Gastroenterol. 2009; 104: 647-54.
11. Lawrance IC, Murray K, Hall A, Sung JJ, Leong R. A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients. Am. J. Gastroenterol. 2004; 99: 2186-94.
12. Lok KH, Hung HG, Ng CH etal. Epidemiology and clinical characteristics of ulcerative colitis in Chinese population: experience from a single center in Hong Kong. J. Gastroenterol. Hepatol. 2008; 23: 406-10.
13. Walker DG, Williams HR, Kane SP etal. Differences in inflammatory bowel disease phenotype between South Asians and Northern Europeans living in North West London, UK. Am. J. Gastroenterol. 2011; 106: 1281-9.
14. Ye BD, Yang S-K, Cho YK etal. Clinical features and long-term prognosis of Crohn's disease in Korea. Scand. J. Gastroenterol. 2010; 45: 1178-85.
15. Huang LJ, Zhu Q, Lei M, Cao Q. Current use of immunosuppressive agents in inflammatory bowel disease patients in East China. World J. Gastroenterol. 2009; 15: 3055-9.
16. Sung JJ, Kamm MA, Marteau P. Asian perspectives in the management of inflammatory bowel disease: findings from a recent survey. J. Gastroenterol. Hepatol. 2010; 25: 183-93.
17. Cao Q, Zhu Q, Shang Y, Gao M, Si J. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease. Digestion 2009; 79: 58-63.
18. Ooi CJ, Fock KM, Makharia GK etal. The Asia-Pacific consensus on ulcerative colitis. J. Gastroenterol. Hepatol. 2010; 25: 453-68.
19. Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005; 54: 237-41.
20. Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J. Predictors of Crohn's disease. Gastroenterology 2006; 130: 650-6.
21. Jess T, Riis L, Vind I. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm. Bowel Dis. 2007; 13: 481-9.
22. Oriuchi T, Hiwatashi N, Kinouchi Y. Clinical course and longterm prognosis of Japanese patients with Crohn's disease: predictive factors, rates of operation, and mortality. J. Gastroenterol. 2003; 38: 942-53.
23. Iida M, Yao T, Okada M. Long-term follow-up study of Crohn's disease in Japan. The Research Committee of Inflammatory Bowel Disease in Japan. J. Gastroenterol. 1995; 30: 17-19.
24. Okada M, Sakurai T, Yao T. Clinical course and long-term prognosis of Crohn's disease in Japan. J. Gastroenterol. 1994; 29: 406-14.
25. Solberg IC, Vatn MH, Hoie O. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clin. Gastroenterol. Hepatol. 2007; 5: 1430-8.
26. Romberg-Camps MJ, Dagnelie PC, Kester AD etal. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am. J. Gastroenterol. 2009; 104: 371-83.
27. Song XM, Gao X, Li MZ etal. Clinical features and risk factors for primary surgery in 205 patients with Crohn's disease: analysis of a South China cohort. Dis. Colon Rectum 2011; 54: 1147-54.
28. Chow DK, Sung JJ, Wu JC, Tsoi KK, Leong RW, Chan FK. Upper gastrointestinal tract phenotype of Crohn's disease is associated with early surgery and further hospitalization. Inflamm. Bowel Dis. 2009; 15: 551-7.
29. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann. Surg. 2000; 231: 38-45.
30. Lindberg E, Jarnerot G, Huitfeldt B. Smoking in Crohn's disease: effect on localisation and clinical course. Gut 1992; 33: 779-82.
31. Hilmi I, Singh R, Ganesananthan S etal. Demography and clinical course of ulcerative colitis in a multiracial Asian population: a nationwide study from Malaysia. J. Dig. Dis. 2009; 10: 15-20.
32. Park SH, Kim YM, Yang SK. Clinical features and natural history of ulcerative colitis in Korea. Inflamm. Bowel Dis. 2007; 13: 278-83.
33. Hiwatashi N, Yao T, Watanabe H. Long-term follow-up study of ulcerative colitis in Japan. J. Gastroenterol. 1995; 30: 13-16.
34. Leijonmarck CE, Persson PG, Hellers G. Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut 1990; 31: 329-33.
35. Hoie O, Wolters FL, Riis L etal. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10years. Gastroenterology 2007; 132: 507-15.
36. Sicilia B, Vicente R, Arroyo MT, Arribas F, Gomollon F. Ulcerative pancolitis predicts the need for colectomy: study of an incident cohort of patients with ulcerative colitis in Aragon (Spain). Gastroenterol. Hepatol. 2005; 28: 55-9.
37. Lee YM, Fock K, See SJ. Racial differences in the prevalence of ulcerative colitis and Crohn's disease in Singapore. J. Gastroenterol. Hepatol. 2000; 15: 622-5.
38. APDW2004 Chinese IBD Working Group. Retrospective analysis of 515 cases of Crohn's disease hospitalization in China: nationwide study from 1990 to 2003. J. Gastroenterol. Hepatol. 2006; 21: 1009-15.
39. Zheng JJ, Zhu XS, Huangfu Z, Shi XH, Guo ZR. Prevalence and incidence rates of Crohn's disease in mainland China: a meta-analysis of 55years of research. J. Dig. Dis. 2010; 11: 161-6.
40. Chow DK, Leong RW, Lai LH etal. Changes in Crohn's disease phenotype over time in the Chinese population: validation of the Montreal classification system. Inflamm. Bowel Dis. 2008; 14: 536-41.
41. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504-17.
42. Vind I, Riis L, Jess T etal. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Am. J. Gastroenterol. 2006; 101: 1274-82.
43. Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-1987: a sixfold increase in incidence. Scand. J. Gastroenterol. 1992; 27: 609-14.
44. Bernstein CN, Wajda A, Svenson LW. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am. J. Gastroenterol. 2006; 101: 1559-68.
45. Fujimoto T, Kato J, Nasu J. Change of clinical characteristics of ulcerative colitis in Japan: analysis of 844 hospital-based patients from 1981 to 2000. Eur. J. Gastroenterol. Hepatol. 2007; 19: 229-35.
46. Yang SK, Yun S, Kim JH etal. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm. Bowel Dis. 2008; 14: 542-9.
47. Park JB, Yang SK, Byeon JS etal. Familial occurrence of inflammatory bowel disease in Korea. Inflamm. Bowel Dis. 2006; 12: 1146-51.
48. Wang YF, Ouyang Q, Hu RW. Progression of inflammatory bowel disease in China. J. Dig. Dis. 2010; 11: 76-82.
49. Su CG, Judge TA, Lichtenstein GR. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol. Clin. North Am. 2002; 31: 307-27.
50. Ng SC, Tsoi KK, Kamm MA etal. Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis. Inflamm. Bowel Dis. 2011; doi: 10.1002/ibd.21845.